By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

BioDelivery Sciences International 

2501 Aerial Center Parkway, Suite 205

Morrisville  North Carolina  27560  U.S.A.
Phone: 919-651-5160 Fax: 919-651-5161


SEARCH JOBS


Industry
Biotechnology

Segment
Drug Delivery





Company News
BioDelivery Sciences International (BDSI) Acquires North American Marketing Authorizations For ONSOLIS From MEDA 1/27/2015 7:33:06 AM
Endo Pharmaceuticals (ENDP) And BioDelivery Sciences International (BDSI) Announce NDA Submission For Buprenorphine Hcl Buccal Film For The Management Of Moderate To Severe Chronic Pain 12/24/2014 7:19:13 AM
BioDelivery Sciences International (BDSI) Launches InReach Support Program For Those Affected By Opioid Dependence 12/10/2014 8:34:06 AM
BioDelivery Sciences International (BDSI) Announces Completion Of Randomization In Phase 3 Trial Of Clonidine Topical Gel For The Treatment Of Painful Diabetic Neuropathy 12/8/2014 8:07:07 AM
BioDelivery Sciences International (BDSI) To Present At The 26th Annual Piper Jaffray Healthcare Conference 11/25/2014 10:43:53 AM
BioDelivery Sciences International (BDSI) To Present At The Stifel 2014 Healthcare Conference And The Jefferies and Co. 2014 Global Healthcare Conference 11/13/2014 8:50:22 AM
BioDelivery Sciences International (BDSI) To Present At The Credit Suisse 2014 Healthcare Conference 11/7/2014 10:00:40 AM
BioDelivery Sciences International (BDSI) Provides Business Review And Update In Conjunction With Filing Of Third Quarter 2014 Financials 11/6/2014 7:50:42 AM
BioDelivery Sciences International (BDSI) Announces The Availability Of BUNAVAILâ„¢ In The U.S. 11/3/2014 8:17:35 AM
BioDelivery Sciences International (BDSI)To Develop A Long-Acting Injectable Depot Formulation Of Buprenorphine With Evonik Industries For Use In Opioid Dependence And Pain 10/28/2014 8:30:53 AM
12345678910...
//-->